Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,760 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and feasibility of S-1 plus oxaliplatin (C-SOX) for treating patients with stage III colon cancer (KSCC1303): final analysis of 3-year disease-free survival.
Ando K, Emi Y, Miyanari N, Tsuji A, Sakai K, Sawai T, Imamura H, Mori S, Tokunaga S, Oki E, Saeki H, Kakeji Y, Akagi Y, Baba H, Maehara Y, Mori M; Kyushu Study Group of Clinical Cancer (KSCC). Ando K, et al. Among authors: imamura h. Int J Clin Oncol. 2020 Jun;25(6):1115-1122. doi: 10.1007/s10147-020-01646-5. Epub 2020 Mar 18. Int J Clin Oncol. 2020. PMID: 32189156 Clinical Trial.
Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.
Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A, Arai K; ACTS-GC Group. Sakuramoto S, et al. Among authors: imamura h. N Engl J Med. 2007 Nov 1;357(18):1810-20. doi: 10.1056/NEJMoa072252. N Engl J Med. 2007. PMID: 17978289 Free article. Clinical Trial.
Multi-center phase II study for combination therapy with paclitaxel/doxifluridine to treat advanced/recurrent gastric cancer showing resistance to S-1 (OGSG 0302).
Takiuchi H, Goto M, Imamura H, Furukawa H, Imano M, Imamoto H, Kimura Y, Ishida H, Fujitani K, Narahara H, Shimokawa T. Takiuchi H, et al. Among authors: imamura h. Jpn J Clin Oncol. 2008 Mar;38(3):176-81. doi: 10.1093/jjco/hyn003. Epub 2008 Feb 16. Jpn J Clin Oncol. 2008. PMID: 18281707 Clinical Trial.
Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002).
Narahara H, Iishi H, Imamura H, Tsuburaya A, Chin K, Imamoto H, Esaki T, Furukawa H, Hamada C, Sakata Y. Narahara H, et al. Among authors: imamura h. Gastric Cancer. 2011 Mar;14(1):72-80. doi: 10.1007/s10120-011-0009-5. Epub 2011 Feb 23. Gastric Cancer. 2011. PMID: 21340666 Free PMC article. Clinical Trial.
Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy.
Tamura S, Fujitani K, Kimura Y, Tsuji T, Matsuyama J, Iijima S, Imamura H, Inoue K, Kobayashi K, Kurokawa Y, Furukawa H; Osaka Gastrointestinal Cancer Chemotherapy Study Group. Tamura S, et al. Among authors: imamura h. Oncology. 2011;80(5-6):296-300. doi: 10.1159/000329090. Epub 2011 Jul 18. Oncology. 2011. PMID: 21778769 Clinical Trial.
Pattern of abdominal nodal spread and optimal abdominal lymphadenectomy for advanced Siewert type II adenocarcinoma of the cardia: results of a multicenter study.
Fujitani K, Miyashiro I, Mikata S, Tamura S, Imamura H, Hara J, Kurokawa Y, Fujita J, Nishikawa K, Kimura Y, Takiguchi S, Mori M, Doki Y. Fujitani K, et al. Among authors: imamura h. Gastric Cancer. 2013 Jul;16(3):301-8. doi: 10.1007/s10120-012-0183-0. Epub 2012 Aug 16. Gastric Cancer. 2013. PMID: 22895616
1,760 results